Clinical Trial: Artificial Intelligence-assisted Primary Care for RSV Prevention (AIPC-RSV) in China

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07856290) titled 'Artificial Intelligence-assisted Primary Care for RSV Prevention (AIPC-RSV) in China' on Sept. 28.

Brief Summary: The goal of this clinical trial is to evaluate whether an AI-assisted primary care intervention for parents can increase RSV monoclonal antibody (mAb) uptake among infants, and to assess the cost-effectiveness and potential for implementing the intervention in routine primary care.

The main questions it aims to answer are:

1. Does the RSV AI-assisted primary care intervention increase parents' perceived risk of RSV disease, RSV prevention literacy, confidence in using RSV mAb, willingness to use RSV mAb for their infant...